Late Breaking Abstract - Economic burden of pertussis among adults 50 years and above: a retrospective observational study in England

2021 ◽  
Author(s):  
Lauriane Harrington ◽  
Emmanuel Aris ◽  
Bhavsar Amit ◽  
Akpo Essè Ifèbi Hervé ◽  
Jason C. Simeone ◽  
...  
Keyword(s):  
Observational Study ◽  
Economic Burden ◽  
Retrospective Observational Study

scholarly journals Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain

2020 ◽  
Vol 23 (5) ◽  
pp. 492-500
Author(s):  
Antoni Sicras-Mainar ◽  
Margarita Capel ◽  
Ruth Navarro-Artieda ◽  
Javier Nuevo ◽  
Marcos Orellana ◽  
...  
Keyword(s):  
Observational Study ◽  
Severe Asthma ◽  
Economic Burden ◽  
Real Life ◽  
Retrospective Observational Study

scholarly journals Economic Burden of Melanoma in Three European Countries: A Retrospective Observational Study

2014 ◽  
Vol 17 (7) ◽  
pp. A626 ◽  
Author(s):  
I. Kontoudis ◽  
M. Harries ◽  
P. Mohr ◽  
F. Grange ◽  
R. Ehness ◽  
...  
Keyword(s):  
Observational Study ◽  
Economic Burden ◽  
European Countries ◽  
Retrospective Observational Study

scholarly journals PRS70 - REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA

2018 ◽  
Vol 21 ◽  
pp. S416
Author(s):  
A. Sicras-Mainar ◽  
M. Capel ◽  
R. Navarro-Artieda ◽  
J. Nuevo ◽  
G. Resler ◽  
...  
Keyword(s):  
Observational Study ◽  
Severe Asthma ◽  
Economic Burden ◽  
Real Life ◽  
Retrospective Observational Study

Hemmkörperentwicklung bei Hämophilie-Patienten nach Präparate wechsel

2012 ◽  
Vol 32 (S 01) ◽  
pp. S39-S42 ◽  
Author(s):  
S. Kocher ◽  
G. Asmelash ◽  
V. Makki ◽  
S. Müller ◽  
S. Krekeler ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Observational Study ◽  
Retrospective Observational Study ◽  
Frequent Change ◽  
Patient Age ◽  
Treatment Regimens ◽  
Patient Âgé ◽  
The Relationship ◽  
Observation Period

SummaryThe retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. Results: During the observation period of 12 months none of the patients developed an inhibitor, which was temporally associated with a change of FVIII products. A frequent change of FVIII products didn’t lead to an increase in inhibitor risk. The change between plasmatic and recombinant preparations could not be confirmed as a risk factor. Furthermore, no correlation between treatment regimens, severity, patient age and comorbidities of the patients could be found.

Sign in / Sign up

Export Citation Format

Share Document